Rentschler Biotechnologie GmbH

https://www.rentschler.de

Rentschler Biotechnologie GmbH, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and biomanufacturing as well as the development of regulatory strategies. The company’s clients include innovative biotech companies as well as major pharmaceutical companies around the world, especially in Europe, North America and Asia. Many years of experience, excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high quality standard. Rentschler is a privately held company employing 650 people. *

	Start	1981-01-01 established
	End	2017-10-01 reorganised
	Group	Rentschler (Group)
	Today	Rentschler Biopharma SE
	Predecessor	Bioferon Biochemische Substanzen GmbH & Co.
	Successor	Rentschler Biopharma SE
	Industry	contract manufacturing (biologicals)
	Person	Mathias, Frank (Oxford Biomedica 202203– CEO before Rentschler + Medigene + Amgen GmbH + Servier DE + Hoechst)
	Person 2	Rentschler, Nikolaus F. (Rentschler Biotechnologie 201604– Supervisory Board before Managing Director (CEO))

	Region	Laupheim
	Country	Germany
	Street	21 Erwin-Rentschler-Str.
	City	88471 Laupheim
	Tel	+49-7392-701-0
		Address record changed: 2020-12-02

Basic data	Employees	E: 501 to 1,000 (2016-09-16)
	Currency	EUR
	Profit	1,932,000 (2012-03-31)

		* Document for »About Section«:

		Record changed: 2023-12-30